SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

Traders are buzzing about ARBB due to its low float and a prior announcement regarding an AI server deal, leading to speculation about a potential short squeeze. Community members are closely monitoring the stock's price action, anticipating a possible breakout and significant upward movement. Comparisons to other low-float runners like $SMX are fueling excitement, with many eyeing it for potential parabolic gains.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta is trending as community members actively discuss its high transaction speeds, regulatory compliance features, and potential as infrastructure for traditional finance to bridge into crypto. Comparisons are drawn against established cryptocurrencies like XRP, Solana, and Avalanche, with many highlighting Keeta's potential for institutional adoption due to its compliance-first design and ties to Stripe. Investors view it as a potentially undervalued asset with significant upside in the evolving financial ecosystem.

Neuberger Berman Energy Infrastructure & Income Fund, Inc. is closed-end mutual fund. It seeks total return with an emphasis on cash distributions by investing in master limited partnerships. The company was founded on November 16, 2012 and is headquartered in New York, NY.

Neuberger Berman Energy Infrastructure and Income Fund Inc

Neuberger Berman MLP Income Fund In

$NML is trending due to discussions around its high-yield distributions and exposure to the energy infrastructure sector, with some investors highlighting its discount to NAV. Recent news of monthly distribution declarations and insider buying seems to be attracting attention. Some are also discussing its holdings in Energy Transfer (ET) and comparing it to other CEFs in the energy sector.

Innoviva, Inc. is engaged in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Burlingame, CA.

Innoviva Inc

Innoviva ($INVA) is trending following FDA approval of zoliflodacin (Nuzolvence) for uncomplicated urogenital gonorrhea, though the community notes commercialization is not expected until the second half of 2026, pending a partnership or independent launch. Discussions revolve around the drug's potential advantage over existing treatments due to its single-dose oral administration, as well as comparisons to GSK's Blujepa. Some investors are also pointing to Innoviva's share repurchase program and stake in Armata Pharmaceuticals as additional factors to consider.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending as the community discusses its potential role in the oracle space, particularly after the U.S. Department of Commerce selected it and Chainlink to deliver economic data on-chain. There's also excitement around a potential token buyback program, with some viewing Pyth as a key player in the Real World Asset (RWA) narrative.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as community members anticipate a significant move, potentially fueled by ongoing consolidation and bullish chart formations. Discussions revolve around Litecoin's established position as "digital silver" and its potential for a parabolic surge, while some compare it to other cryptocurrencies. Talk about upcoming catalysts is circulating in the community.

Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need. Its platform utilizes custom-built throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue, initially focused on addressing rare neuromuscular and cardiac diseases. The company was founded by Badreddin Edris, Alan Russel and Peter A. Thompson in 2017 and is headquartered in Boulder, CO.

Edgewise Therapeutics Inc

Edgewise Therapeutics is trending due to positive early data on its heart disease drug, EDG-7500, showing promise in reducing heart failure biomarkers without impacting heart function, potentially differentiating it from existing treatments. The community is closely watching for upcoming Phase 2 trial results, as analysts see significant upside potential if the drug demonstrates continued efficacy and a favorable safety profile. The company's strong financial position and multiple upcoming catalysts have made it a subject of buyout speculation.

XPLR Infrastructure LP engages in the acquisition, management, and ownership of contracted clean energy portfolios with long-term cash flows. It focuses on battery storage, solar, and wind initiatives. The company was founded on March 6, 2014 and is headquartered in Juno Beach, FL.

XPLR Infrastructure LP. - Unit

XIFR is trending due to a potential deep value opportunity, with analysts highlighting a significant discount between its book value and current share price. Community members are discussing institutional buying activity and the potential for a turnaround driven by contracted cash flows and increasing energy demand. Investors are weighing management's strategy against debt concerns and CEPF structures.

American Superconductor Corp. engages in the provision of megawatt-scale power solutions. Its products include electric control systems, generators & drivetrains, power converters, renewable interconnectivity solutions, software, turbine designs, utility and industrial resilience and modernization solutions, and utility voltage solutions. It operates through the Grid and Wind segments. The Grid segment enables electric utilities and renewable energy project developers to connect, transmit, and distribute power with efficiency, reliability, security, and affordability. The Wind segment permits the manufacturers to field wind turbines with power output, reliability, and affordability. The company was founded by Yet Ming Chiang, David A. Rudman, John B. Vander Sande, and Gregory J. Yurek on April 9, 1987 and is headquartered in Ayer, MA.

American Superconductor Corp.

AMSC is trending as community members discuss the potential impact of increased Navy business and Clear Street's updated rating to Buy. Conversations also highlight the company's involvement in ship production and potential benefits from grid modernization and EMP protection solutions. Some investors are calling for management to consider shareholder dividends amid discussions of tariffs and potential superconductor collaboration.

Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease. The company was founded by Brian Taylor Slingsby on May 31, 2019 and is headquartered in Radnor, PA.

Mineralys Therapeutics Inc

MLYS is trending due to recent actionable trade alerts pointing towards a bullish reversal, driven by an oversold RSI and proximity to its 60-day low. The community is actively discussing potential entry points and ROI targets, with some noting accumulation of contracts and potential for significant gains. Broader interest in the stock is also related to its development of Lorundorestat, with anticipation of data in Q1 2026 to address OSA.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$PATH
We called it...

A couple of days ago we mentioned that a pullback for price was expected and needed. Sur enough, that is exactly what is happening

We are still targeting the 0.5 fib level that has confluence with the daily 21EMA

Honestly, No Body

StockTwits for iOS

UiPath Inc


We called it...

A couple of days ago we mentioned that a pullback for price was expected and needed. Sur enough, that is exactly what is happening

We are still targeting the 0.5 fib level that has confluence with the daily 21EMA

Markus Heikteotter

@Markus01 yep. I sold at 19 and will buy back at 16

StockTwits For Android 

 yep. I sold at 19 and will buy back at 16